Dr. Bruce M. McCormack, MD

Dr. McCormack practices at Neurospine Institute Medical Group in San Francisco, California.

Dr. McCormack's NPI, 1184636425, was assigned on August 13, 2006. Dr. McCormack graduated from Vagelos College of Physicians and Surgeons in 1986. Dr. McCormack holds California license G078326.

Dr. McCormack's primary practice is Neurospine Institute Medical Group, at 2320 Sutter St Ste 202 Suite 202, San Francisco, CA 94115. The practice phone is (415) 923-9222.

Dr. McCormack's primary practice is Neurospine Institute Medical Group in San Francisco, California. Dr. McCormack is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Sutter Santa Rosa Regional Hospital. Dmand AI also links Dr. McCormack to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McCormack practices, 6 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. McCormack's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. McCormack is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. McCormack's licenses on file in 5 states: California, New Mexico, Connecticut, New York and Florida.

Dmand AI lists back and neck pain treatment without fusion, craniotomy, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal fusion and thoracic spine disorders among the conditions Dr. McCormack treats.

CMS data shows 494 Medicare services from Dr. McCormack across 11 procedure codes in 2024, for 254 Medicare patients. Medicare paid $68,867 for them.

CMS counts 254 Medicare patients who saw Dr. McCormack in 2024. The largest group is 75 to 84, with 107 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McCormack's median patient age at 72, with 49% women.

In 2024, Dr. McCormack wrote 140 Medicare Part D claims for 64 patients. 99% of them were for generic drugs. CMS names the drug for 91 of them, across 5 drugs with 11 or more claims each, at $961 in total drug cost. In 2023, CMS named 90 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. McCormack for performance year 2024, reported individually. Dr. McCormack accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 64 procedures of laminectomy or laminotomy (partial removal of spine bones) by Dr. McCormack, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 18 papers to Dr. McCormack, published from 2012 to 2025. 2013 was the busiest year, with 3. The most frequent topics are Spinal Fusion, Cervical Vertebrae and Carpal Tunnel Syndrome. Dr. McCormack has published most often in J Clin Neurosci. Dr. McCormack's most frequent co-authors are Mark C. Gillespy, MD, Mukund I. Gundanna, MD and Michael M. Haglund, MD.

CMS Open Payments shows 184 general payments to Dr. McCormack from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. Providence Medical Technology, Inc. paid the most, $254,783.

Dmand AI lists 1 award for Dr. McCormack.

Dr. McCormack graduated from Vagelos College of Physicians and Surgeons in 1986. Dr. McCormack is a member of AANS and CNS.

Dr. McCormack is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.